You're viewing this item in the new Europeana website. View this item in the original Europeana.

Plasma concentrations of fibroblast growth factors 21 and 19 in patients with Cushing's syndrome

The objective of this study was to measure plasma fibroblast growth factor 21 and 19 (FGF21 and FGF19) levels in patients with Cushing's syndrome (CS) and to compare it with those of lean control subjects (C) and patients with obesity (OB). Fourteen untreated patients with CS, 19 patients with OB and 36 controls were included in the study. Plasma FGF21 and FGF19 levels were measured by ELISA kits,…